The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

@article{Kesselheim2016TheHC,
  title={The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.},
  author={Aaron S Kesselheim and Jerry Avorn and Ameet Sarpatwari},
  journal={JAMA},
  year={2016},
  volume={316 8},
  pages={
          858-71
        }
}
IMPORTANCE The increasing cost of prescription drugs in the United States has become a source of concern for patients, prescribers, payers, and policy makers. OBJECTIVES To review the origins and effects of high drug prices in the US market and to consider policy options that could contain the cost of prescription drugs. EVIDENCE We reviewed the peer-reviewed medical and health policy literature from January 2005 to July 2016 for articles addressing the sources of drug prices in the United… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 128 CITATIONS, ESTIMATED 48% COVERAGE

ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes

VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

CRISPR, Patents, and the Public Health



VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Drug Pricing and Trust: the Time Is Right

  • Julie Babyar
  • Engineering
  • Journal of Pharmaceutical Innovation
  • 2017
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs

VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2016
2020

CITATION STATISTICS

  • 9 Highly Influenced Citations

  • Averaged 39 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 129 REFERENCES

CREATES Act of 2016 (S 3056)

  • US Senate
  • 14 Jun 2016. https://www.congress.gov/bill/114th -congress/senate-bill/3056/text. Accessed July 13,
  • 2016

Drugmakers’ pricing power remains strong. Wall Street Journal. http://www.wsj.com /articles/drugmakers-pricing-power-remains -strong-1468488601

  • J. Walker
  • Published July
  • 2016

Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA)

  • J. Woodcock
  • Testimony before the Committee on Health, Education, Labor and Pensions United States Senate. January
  • 2016